×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 2: Defining Return on Engagement – Measuring What Matters
Session Chair(s)
Roslyn Schneider, MD, FACP
Vice President, Head of Global Patient Affairs
Biomarin Pharmaceuticals Inc., United States
Session 2: Defining Return on Engagement – Measuring What Matters
Speaker(s)
Speaker
Alan B. Rosenberg
Alanbrosenberg Healthcare Consulting, Inc., United States
President
Speaker
Karlin Schroeder, MA
Parkinson's Foundation, United States
Associate Vice President, Community Engagement
Speaker
Kathryn O'Callaghan
FDA, United States
Assistant Director for Strategic Programs, CDRH
Speaker
Roslyn Schneider, MD, FACP
Biomarin Pharmaceuticals Inc., United States
Vice President, Head of Global Patient Affairs
Speaker
Christine Pierre, RN
Society for Clinical Research Sites, United States
President
Speaker
Ron Wincek
Interactive Advantage Corporation, United States
CEO